![Alexandra Tolia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexandra Tolia
Directeur/Membre du Conseil chez
FORMAC Pharmaceuticals NV
Profil
Alexandra Tolia currently works at FORMAC Pharmaceuticals NV, as Director, FEops NV, as Director, Confo Therapeutics NV, as Director, eTheRNA immunotherapies NV, as Director, Epics Therapeutics SA, as Director from 2019, and Ona Therapeutics SL, as Director from 2020.
Dr. Tolia also formerly worked at Exact Imaging, Inc., as Director, Multiplicom NV, as Non-Executive Director, iTeos Therapeutics SA, as Director, Participatiemaatschappij Vlaanderen NV, as Business Manager Venture Capital in 2018, Hunza Management SARL, as Investment Manager from 2011 to 2014, and Fund+, as Partner from 2018 to 2022.
Dr. Tolia received her undergraduate degree from Université Libre de Bruxelles, undergraduate degree from Solvay Business School of Economics & Management, and doctorate degree in 2008 from Katholieke Universiteit Leuven.
Postes actifs de Alexandra Tolia
| Sociétés | Poste | Début |
|---|---|---|
FORMAC Pharmaceuticals NV
 FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology Engages in drug delivery and development services | Directeur/Membre du Conseil | - |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Directeur/Membre du Conseil | - |
FEops NV
 FEops NV Information Technology ServicesTechnology Services Develops AI-driven simulation technology and related platform for clinical heart interventions | Directeur/Membre du Conseil | - |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases | Directeur/Membre du Conseil | 16/06/2020 |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Directeur/Membre du Conseil | 04/02/2019 |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Alexandra Tolia
| Sociétés | Poste | Fin |
|---|---|---|
Fund+
 Fund+ Investment ManagersFinance Fund+ invests in companies located in Europe primarily in Belgium. The firm focuses on the life sciences primarily active in therapeutics, as well as companies developing diagnostics and medical devices.. It participates in early stage capital requirements with an investment of EUR 5 - 15 million. The firm acquires minority interest and takes a seat on the board of directors. It also makes co-investments and subsequent financing. | Private Equity Investor | 01/11/2022 |
Participatiemaatschappij Vlaanderen NV
 Participatiemaatschappij Vlaanderen NV Investment ManagersFinance PMV invests in companies located in Belgium. The firm focuses on a broad range of sectors and industries. It participates in equity and debt in seed stage, early stage, late stage and growth stage transactions with an investment size up to EUR 20 million. It consider minority investments and also makes co-investments. | Private Equity Investor | 01/12/2018 |
Hunza Management SARL
 Hunza Management SARL Investment ManagersFinance Hunza is a venture capital investor focused on sectors including biotechnology, pharmaceuticals, medical technology and medical services. They also invest in high-tech industries such as software, energy, environmental technology, Internet and media. The firm targets companies with high-value creation potential and leverages their business experience, knowledge and networks to turn them into market leaders. They invest across development stages in seed, startup and expansion financing. Hunza invests globally through shareholder loans, majority or significant minority equity participations, mezzanine and bridge financing. Their investments have included traditional Chinese medicine, oncology, drug delivery technology and minimally-invasive medical devices for heart surgery. | Private Equity Investor | 01/10/2014 |
| ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Alexandra Tolia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Participatiemaatschappij Vlaanderen NV
Participatiemaatschappij Vlaanderen NV Investment ManagersFinance PMV invests in companies located in Belgium. The firm focuses on a broad range of sectors and industries. It participates in equity and debt in seed stage, early stage, late stage and growth stage transactions with an investment size up to EUR 20 million. It consider minority investments and also makes co-investments. | Finance |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology Engages in drug delivery and development services | Health Technology |
Hunza Management SARL
Hunza Management SARL Investment ManagersFinance Hunza is a venture capital investor focused on sectors including biotechnology, pharmaceuticals, medical technology and medical services. They also invest in high-tech industries such as software, energy, environmental technology, Internet and media. The firm targets companies with high-value creation potential and leverages their business experience, knowledge and networks to turn them into market leaders. They invest across development stages in seed, startup and expansion financing. Hunza invests globally through shareholder loans, majority or significant minority equity participations, mezzanine and bridge financing. Their investments have included traditional Chinese medicine, oncology, drug delivery technology and minimally-invasive medical devices for heart surgery. | Finance |
Exact Imaging, Inc.
 Exact Imaging, Inc. Medical SpecialtiesHealth Technology Develops micro-ultrasound systems | Health Technology |
Multiplicom NV
 Multiplicom NV Medical SpecialtiesHealth Technology Operates a quality management system to design, develop, manufacture and distribute CE-IVD products | Health Technology |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Health Technology |
Solvay Business School of Economics & Management
 Solvay Business School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FEops NV
FEops NV Information Technology ServicesTechnology Services Develops AI-driven simulation technology and related platform for clinical heart interventions | Technology Services |
Fund+
Fund+ Investment ManagersFinance Fund+ invests in companies located in Europe primarily in Belgium. The firm focuses on the life sciences primarily active in therapeutics, as well as companies developing diagnostics and medical devices.. It participates in early stage capital requirements with an investment of EUR 5 - 15 million. The firm acquires minority interest and takes a seat on the board of directors. It also makes co-investments and subsequent financing. | Finance |
Confo Therapeutics NV
Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Health Technology |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Ona Therapeutics SL
Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases | Health Technology |
